Back to results
US 2017/0290812 A1Published application
Methods of treatment for cholestatic and fibrotic diseases
AssigneeGenfit
InventorsRAPHAEL DARTEIL, ROBERT WALCZAK, CAROLE BELANGER, EMILIE NEGRO, PIERRE DAUBERSIES, PHILIPPE DELATAILLE
Life of this patent
Estimating the term…
Abstract
The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
Claims11
A method of treating a cholestatic or fibrotic disorder comprising administering a compound selected from the group consisting of Nitazoxanide (NTZ), Tizoxanide (TZ), Tizoxanide glucuronide (TZG), and a pharmaceutically acceptable salt of NTZ, TZ or TZG to a subject having a cholestatic or fibrotic disorder.
Dependencies are inferred from the claim text.